These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9281153)

  • 41. [Clinical results of perftorane use in comprehensive treatment of patients with odontogenic phlegmons].
    Durnovo EA; Furman IV
    Stomatologiia (Mosk); 2007; 86(4):35-9. PubMed ID: 17828096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The diagnosis and treatment of odontogenic mediastinitis].
    Gubin MA; Girko EI; Kharitonov IuM
    Vestn Khir Im I I Grek; 1996; 155(3):12-5. PubMed ID: 8966928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hemosorption in the combined therapy of suppurative-septic processes of the maxillofacial area].
    Zakharov IuS; Bolgov DF
    Stomatologiia (Mosk); 1985; 64(3):45-7. PubMed ID: 3863281
    [No Abstract]   [Full Text] [Related]  

  • 44. [Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
    Shimchenko PIa; Morozov VG; Khavinson VKh; Orlov VS
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):94-7. PubMed ID: 6895567
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bacteriophage and proteolytic enzymes in the treatment of odontogenic abscesses and phlegmons].
    Kats AG; Biberman IaM; Zabokritskaia DM; Malomud ZP; Starodubtsev VS
    Stomatologiia (Mosk); 1980; 59(2):29-31. PubMed ID: 6445610
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of suppurative wound dialysis in the overall treatment of phlegmons of the face and neck].
    Shalumov AZ; Robustova TG; Nerobeev AI; Karaian AS
    Khirurgiia (Mosk); 1980 Nov; (11):23-7. PubMed ID: 7003212
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinico-therapeutic observations on a series of cases of odontogenic abscesses and phlegmons].
    Miconi M; Gallesio C; Berrone S
    Minerva Stomatol; 1991 Oct; 40(10):641-9. PubMed ID: 1803221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pathogenetic basis for ozone therapy as a modality to treat vibration disease (literature review)].
    Kir'iakov VA; Saarkoppel' LM; Zheglova AV
    Med Tr Prom Ekol; 2006; (5):12-6. PubMed ID: 16813227
    [No Abstract]   [Full Text] [Related]  

  • 49. [The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Tarasenko SV; Aleksashina IP; Agapov VS; Trukhina GM; Liapunov NA
    Stomatologiia (Mosk); 2000; 79(2):17-9. PubMed ID: 10812984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preparation glycosaminosulphate efficacy in comprehensive treatment of patients with odontogenic phlegmon of maxillofacial region].
    Mingazov GG; Garaishin RM; Mavziutov AR; Suleimanov AM
    Stomatologiia (Mosk); 2009; 88(6):29-31. PubMed ID: 20081776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The structural and etiological characteristics of inflammatory diseases of the maxillofacial area].
    Kislykh FI; Urazova IV
    Stomatologiia (Mosk); 1996; Spec No():61-2. PubMed ID: 9281154
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of heteroperitoneum in the treatment of maxillofacial phlegmons].
    Gurov PN; Balmukhanov VN
    Vestn Khir Im I I Grek; 1970 Aug; 105(8):13-6. PubMed ID: 5495080
    [No Abstract]   [Full Text] [Related]  

  • 53. [Differentiated premedication in the treatment of odontogenic phlegmons of the maxillofacial area].
    Vovk IuV; Gotsko EV; Kaminskiĭ VI
    Stomatologiia (Mosk); 1988; 67(5):40-2. PubMed ID: 3212805
    [No Abstract]   [Full Text] [Related]  

  • 54. [The use of physiotherapeutic factors in the combined treatment of patients with diseases of the maxillofacial area].
    Ivasenko PI; Popov AK; Ponomarenko ID
    Stomatologiia (Mosk); 1996; Spec No():59-60. PubMed ID: 9281151
    [No Abstract]   [Full Text] [Related]  

  • 55. Length of hospital stay and management of facial cellulitis of odontogenic origin in children.
    Kara A; Ozsurekci Y; Tekcicek M; Karadag Oncel E; Cengiz AB; Karahan S; Ceyhan M; Celik MO; Ozkaya-Parlakay A
    Pediatr Dent; 2014; 36(1):18E-22E. PubMed ID: 24717702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of a transport medium for isolating asporogenic anaerobes from clinical specimens in odontogenic phlegmon].
    Oleĭnik II; Bychenko BD; Robustova TG; Ushakov RV; Terekhova EV
    Stomatologiia (Mosk); 1984; 63(5):35-7. PubMed ID: 6593913
    [No Abstract]   [Full Text] [Related]  

  • 57. [The status and outlook in the prevention and treatment of suppurative inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Kozlov VA; Robustova TG; Maksimovskiĭ IuM
    Stomatologiia (Mosk); 1997; 76(2):15-9. PubMed ID: 9163076
    [No Abstract]   [Full Text] [Related]  

  • 58. [The prediction of the outcomes of severe odontogenic inflammatory diseases of the maxillofacial area taking into account biorhythms].
    Taĭchenachev AIa
    Stomatologiia (Mosk); 1998; 77(6):15-8. PubMed ID: 10067408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Homeostatic disorders and their correction in a program of combined treatment in odontogenic sepsis].
    Kharitonov IuM; Lunev BV; Lazutikov OV; Chevardov NI
    Stomatologiia (Mosk); 1996; Spec No():86-7. PubMed ID: 9281189
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experience in medical ozone use for root canal treatment].
    Bezrukova IV; Petrukhina NB; Voinov PA
    Stomatologiia (Mosk); 2005; 84(6):20-2. PubMed ID: 16353031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.